Remarkably, the capability of MYCN to activate the expression of critical oncomirs, such as miR-221, miR-9, or the miR-17-92 cluster, has also been observed in neuroblastoma cells and other types of solid tumor cells (80). The gene discussed is MYCN; the disease is neuroblastoma.